Drug Contamination Data On Semipermeable Vials Should Be Collected By FDA
FDA needs to collect toxicology data on the potential contamination of drug products packaged in semipermeable containers, the agency's Drug Safety & Risk Management Advisory Committee recommended
You may also be interested in...
Inhalation drug products in semipermeable containers should be individually wrapped with secondary packaging to prevent environmental contamination of the drug product, an FDA draft guidance says
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials